Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Non Operating Income: 2021-2025

Historic Non Operating Income for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to -$112.4 million.

  • Roivant Sciences' Non Operating Income fell 291.88% to -$5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$21.2 million, marking a year-over-year decrease of 372.67%. This contributed to the annual value of -$112.4 million for FY2025, which is 109.39% down from last year.
  • Per Roivant Sciences' latest filing, its Non Operating Income stood at -$112.4 million for FY2025, which was down 109.39% from $1.2 billion recorded in FY2024.
  • Roivant Sciences' Non Operating Income's 5-year high stood at $1.2 billion during FY2024, with a 5-year trough of -$179.0 million in FY2022.
  • In the last 3 years, Roivant Sciences' Non Operating Income had a median value of -$112.4 million in 2025 and averaged $307.1 million.
  • In the last 5 years, Roivant Sciences' Non Operating Income slumped by 1,957.23% in 2022 and then spiked by 833.86% in 2024.
  • Roivant Sciences' Non Operating Income (Yearly) stood at -$8.7 million in 2021, then plummeted by 1,957.23% to -$179.0 million in 2022, then grew by 8.89% to -$163.1 million in 2023, then soared by 833.86% to $1.2 billion in 2024, then slumped by 109.39% to -$112.4 million in 2025.